Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lutz Naehrlich

Showing results (21-30 of 81) with videos related to

Pageof 9
Sort By:
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 11, 2014
Nasal potential difference: Best or average result for CFTR function as diagnostic criteria for cystic fibrosis?Katherine Keenan, Julie Avolio, Claudia Rueckes-Nilges, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 30, 2023
Use of elexacaftor/tezacaftor/ivacaftor leads to changes in detection frequencies of Staphylococcus aureus and Pseudomonas aeruginosa dependent on age and lung function in people with cystic fibrosisAnna-Maria Dittrich, Sarah Sieber, Lutz Naehrlich, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 3, 2023
Epidemiological trends in nontuberculous mycobacterial infection among people with cystic fibrosis in GermanyMathis Steindor, Sylvia Hafkemeyer, Christian Ruckes, et al.
Annals of the American Thoracic Society|September 10, 2025
Health Inequity in People with Cystic Fibrosis: Can We Close the Gap?Isabelle Sermet-Gaudelus, Annalisa Orenti, Elpis Hatziagorou, et al.
The European Respiratory Journal|February 1, 2024
Cystic fibrosis in Europe: improved lung function and longevity - reasons for cautious optimism, but challenges remainEitan Kerem, Annalisa Orenti, Arianna Adamoli, et al.
Infection and Immunity|June 8, 2011
Serine proteases degrade airway mucins in cystic fibrosisMarkus O Henke, Gerrit John, Christina Rheineck, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 26, 2026
Partnership between cystic fibrosis centres in Europe: The Twinning ProjectPavel Drevinek, Helen K Chadwick, Katarina Stepankova, et al.
Plos One|June 3, 2017
Assessment of pathologic increase in liver stiffness enables earlier diagnosis of CFLD: Results from a prospective longitudinal cohort studyVictoria Klotter, Caroline Gunchick, Enno Siemers, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 15, 2020
Defective BACH1/HO-1 regulatory circuits in cystic fibrosis bronchial epithelial cellsShashipavan Chillappagari, Virajith Garapati, Poornima Mahavadi, et al.
Therapeutic Advances in Chronic Disease|August 12, 2022
Personalized medicine with drugs targeting the underlying protein defect in cystic fibrosis: is monitoring of treatment response necessary?Katharina Niedermayr, Verena Gasser, Claudia Rueckes-Nilges, et al.
Pageof 9

Showing results (21-30 of 81) with videos related to

Sort By:
Pageof 9
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 11, 2014
Nasal potential difference: Best or average result for CFTR function as diagnostic criteria for cystic fibrosis?Katherine Keenan, Julie Avolio, Claudia Rueckes-Nilges, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 30, 2023
Use of elexacaftor/tezacaftor/ivacaftor leads to changes in detection frequencies of Staphylococcus aureus and Pseudomonas aeruginosa dependent on age and lung function in people with cystic fibrosisAnna-Maria Dittrich, Sarah Sieber, Lutz Naehrlich, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 3, 2023
Epidemiological trends in nontuberculous mycobacterial infection among people with cystic fibrosis in GermanyMathis Steindor, Sylvia Hafkemeyer, Christian Ruckes, et al.
Annals of the American Thoracic Society|September 10, 2025
Health Inequity in People with Cystic Fibrosis: Can We Close the Gap?Isabelle Sermet-Gaudelus, Annalisa Orenti, Elpis Hatziagorou, et al.
The European Respiratory Journal|February 1, 2024
Cystic fibrosis in Europe: improved lung function and longevity - reasons for cautious optimism, but challenges remainEitan Kerem, Annalisa Orenti, Arianna Adamoli, et al.
Infection and Immunity|June 8, 2011
Serine proteases degrade airway mucins in cystic fibrosisMarkus O Henke, Gerrit John, Christina Rheineck, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 26, 2026
Partnership between cystic fibrosis centres in Europe: The Twinning ProjectPavel Drevinek, Helen K Chadwick, Katarina Stepankova, et al.
Plos One|June 3, 2017
Assessment of pathologic increase in liver stiffness enables earlier diagnosis of CFLD: Results from a prospective longitudinal cohort studyVictoria Klotter, Caroline Gunchick, Enno Siemers, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 15, 2020
Defective BACH1/HO-1 regulatory circuits in cystic fibrosis bronchial epithelial cellsShashipavan Chillappagari, Virajith Garapati, Poornima Mahavadi, et al.
Therapeutic Advances in Chronic Disease|August 12, 2022
Personalized medicine with drugs targeting the underlying protein defect in cystic fibrosis: is monitoring of treatment response necessary?Katharina Niedermayr, Verena Gasser, Claudia Rueckes-Nilges, et al.
Pageof 9